# Yelp Inc: financial statements, quarterly

YELP · NYSE · CIK 1345016 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yelp.md) · [Financials](/companies/yelp/financials.md) · [Filings](/companies/yelp/filings.md) · [Insiders](/companies/yelp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yelp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [345](/filings/0001345016-24-000060.md) | [342 d](/filings/0001345016-26-000019.md) | [333](/filings/0001345016-25-000030.md) | [357](/filings/0001345016-25-000041.md) | [360](/filings/0001345016-25-000071.md) | [362 d](/filings/0001345016-26-000019.md) | [359](/filings/0001345016-26-000040.md) | [370](/filings/0001345016-26-000066.md) | [376](/filings/0001345016-25-000071.md) | [360 d](/filings/0001345016-26-000019.md) | [361](/filings/0001345016-26-000040.md) | [376](/filings/0001345016-26-000066.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [41.9](/filings/0001345016-24-000060.md) | [25.0 d](/filings/0001345016-26-000019.md) | [11.2](/filings/0001345016-25-000030.md) | [39.7](/filings/0001345016-25-000041.md) | [46.7](/filings/0001345016-25-000071.md) | [53.4 d](/filings/0001345016-26-000019.md) | [29.5](/filings/0001345016-26-000040.md) | [53.3](/filings/0001345016-26-000066.md) | [52.9](/filings/0001345016-25-000071.md) | [48.9 d](/filings/0001345016-26-000019.md) | [27.3](/filings/0001345016-26-000040.md) | [43.7](/filings/0001345016-26-000066.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001345016-26-000066.md) | not reported | not reported | not reported | [1.6](/filings/0001345016-26-000066.md) |
| Income tax | $m | [(10.2)](/filings/0001345016-24-000060.md) | [6.4 d](/filings/0001345016-26-000019.md) | [4.8](/filings/0001345016-25-000030.md) | [12.0](/filings/0001345016-25-000041.md) | [15.4](/filings/0001345016-25-000071.md) | [17.8 d](/filings/0001345016-26-000019.md) | [10.8](/filings/0001345016-26-000040.md) | [14.9](/filings/0001345016-26-000066.md) | [18.9](/filings/0001345016-25-000071.md) | [13.8 d](/filings/0001345016-26-000019.md) | [12.1](/filings/0001345016-26-000040.md) | [12.8](/filings/0001345016-26-000066.md) |
| Net income | $m | [58.2](/filings/0001345016-24-000060.md) | [27.4 d](/filings/0001345016-26-000019.md) | [14.2](/filings/0001345016-25-000030.md) | [38.0](/filings/0001345016-25-000041.md) | [38.4](/filings/0001345016-25-000071.md) | [42.2 d](/filings/0001345016-26-000019.md) | [24.4](/filings/0001345016-26-000040.md) | [44.1](/filings/0001345016-26-000066.md) | [39.3](/filings/0001345016-25-000071.md) | [37.8 d](/filings/0001345016-26-000019.md) | [17.7](/filings/0001345016-26-000040.md) | [31.7](/filings/0001345016-26-000066.md) |
| Diluted EPS | $ per share | [0.79](/filings/0001345016-24-000060.md) | not reported | [0.20](/filings/0001345016-25-000030.md) | [0.54](/filings/0001345016-25-000041.md) | [0.56](/filings/0001345016-25-000071.md) | not reported | [0.36](/filings/0001345016-26-000040.md) | [0.67](/filings/0001345016-26-000066.md) | [0.61](/filings/0001345016-25-000071.md) | not reported | [0.30](/filings/0001345016-26-000040.md) | [0.57](/filings/0001345016-26-000066.md) |
| Basic EPS | $ per share | [0.84](/filings/0001345016-24-000060.md) | not reported | [0.21](/filings/0001345016-25-000030.md) | [0.56](/filings/0001345016-25-000041.md) | [0.57](/filings/0001345016-25-000071.md) | not reported | [0.37](/filings/0001345016-26-000040.md) | [0.69](/filings/0001345016-26-000066.md) | [0.62](/filings/0001345016-25-000071.md) | not reported | [0.30](/filings/0001345016-26-000040.md) | [0.57](/filings/0001345016-26-000066.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [305](/filings/0001345016-23-000057.md) | [314](/filings/0001345016-25-000007.md) | [296](/filings/0001345016-24-000033.md) | [252](/filings/0001345016-24-000052.md) | [262](/filings/0001345016-24-000060.md) | [217](/filings/0001345016-26-000019.md) | [222](/filings/0001345016-25-000030.md) | [198](/filings/0001345016-25-000041.md) | [231](/filings/0001345016-25-000071.md) | [216](/filings/0001345016-26-000066.md) | [110](/filings/0001345016-26-000040.md) | [94.1](/filings/0001345016-26-000066.md) |
| Current assets | $m | [626](/filings/0001345016-23-000057.md) | [624](/filings/0001345016-25-000007.md) | [607](/filings/0001345016-24-000033.md) | [584](/filings/0001345016-24-000052.md) | [590](/filings/0001345016-24-000060.md) | [517](/filings/0001345016-26-000019.md) | [528](/filings/0001345016-25-000030.md) | [509](/filings/0001345016-25-000041.md) | [550](/filings/0001345016-25-000071.md) | [515](/filings/0001345016-26-000066.md) | [302](/filings/0001345016-26-000040.md) | [294](/filings/0001345016-26-000066.md) |
| Total assets | $m | [1,027](/filings/0001345016-23-000057.md) | [1,015](/filings/0001345016-25-000007.md) | [993](/filings/0001345016-24-000033.md) | [965](/filings/0001345016-24-000052.md) | [980](/filings/0001345016-24-000060.md) | [984](/filings/0001345016-26-000019.md) | [985](/filings/0001345016-25-000030.md) | [980](/filings/0001345016-25-000041.md) | [990](/filings/0001345016-25-000071.md) | [958](/filings/0001345016-26-000066.md) | [1,013](/filings/0001345016-26-000040.md) | [991](/filings/0001345016-26-000066.md) |
| Current liabilities | $m | [190](/filings/0001345016-23-000057.md) | [176](/filings/0001345016-25-000007.md) | [191](/filings/0001345016-24-000033.md) | [158](/filings/0001345016-24-000052.md) | [170](/filings/0001345016-24-000060.md) | [155](/filings/0001345016-26-000019.md) | [182](/filings/0001345016-25-000030.md) | [156](/filings/0001345016-25-000041.md) | [184](/filings/0001345016-25-000071.md) | [172](/filings/0001345016-26-000066.md) | [174](/filings/0001345016-26-000040.md) | [168](/filings/0001345016-26-000066.md) |
| Total liabilities | $m | [288](/filings/0001345016-23-000057.md) | [265](/filings/0001345016-25-000007.md) | [272](/filings/0001345016-24-000033.md) | [230](/filings/0001345016-24-000052.md) | [241](/filings/0001345016-24-000060.md) | [240](/filings/0001345016-26-000019.md) | [257](/filings/0001345016-25-000030.md) | [234](/filings/0001345016-25-000041.md) | [257](/filings/0001345016-25-000071.md) | [248](/filings/0001345016-26-000066.md) | [382](/filings/0001345016-26-000040.md) | [346](/filings/0001345016-26-000066.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [740](/filings/0001345016-24-000060.md) | [750](/filings/0001345016-26-000019.md) | [722](/filings/0001345016-25-000041.md) | [735](/filings/0001345016-25-000071.md) | [740](/filings/0001345016-25-000071.md) | [744](/filings/0001345016-26-000066.md) | [728](/filings/0001345016-26-000066.md) | [746](/filings/0001345016-26-000066.md) | [733](/filings/0001345016-25-000071.md) | [711](/filings/0001345016-26-000066.md) | [631](/filings/0001345016-26-000066.md) | [645](/filings/0001345016-26-000066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [105 d](/filings/0001345016-24-000060.md) | [79.2 d](/filings/0001345016-26-000019.md) | [72.9](/filings/0001345016-25-000030.md) | [39.7 d](/filings/0001345016-25-000041.md) | [102 d](/filings/0001345016-25-000071.md) | [71.0 d](/filings/0001345016-26-000019.md) | [98.0](/filings/0001345016-26-000040.md) | [58.0 d](/filings/0001345016-26-000066.md) | [132 d](/filings/0001345016-25-000071.md) | [84.5 d](/filings/0001345016-26-000019.md) | [57.8](/filings/0001345016-26-000040.md) | [75.8 d](/filings/0001345016-26-000066.md) |
| Capital expenditure | $m | [5.7 d](/filings/0001345016-24-000060.md) | [6.0 d](/filings/0001345016-26-000019.md) | [7.0](/filings/0001345016-25-000030.md) | [9.6 d](/filings/0001345016-25-000041.md) | [9.8 d](/filings/0001345016-25-000071.md) | [11.0 d](/filings/0001345016-26-000019.md) | [10.5](/filings/0001345016-26-000040.md) | [13.0 d](/filings/0001345016-26-000066.md) | [12.6 d](/filings/0001345016-25-000071.md) | [12.2 d](/filings/0001345016-26-000019.md) | [12.7](/filings/0001345016-26-000040.md) | [14.7 d](/filings/0001345016-26-000066.md) |
| Share repurchases | $m | [50.0 d](/filings/0001345016-24-000060.md) | [50.0 d](/filings/0001345016-26-000019.md) | [62.5](/filings/0001345016-25-000030.md) | [60.2 d](/filings/0001345016-25-000041.md) | [65.7 d](/filings/0001345016-25-000071.md) | [62.5 d](/filings/0001345016-26-000019.md) | [62.5](/filings/0001345016-26-000040.md) | [66.0 d](/filings/0001345016-26-000066.md) | [75.0 d](/filings/0001345016-25-000071.md) | [87.5 d](/filings/0001345016-26-000019.md) | [124](/filings/0001345016-26-000040.md) | [50.0 d](/filings/0001345016-26-000066.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.7](/filings/0001345016-23-000057.md) | [69.8](/filings/0001345016-24-000033.md) | [71.2](/filings/0001345016-24-000052.md) | [73.6](/filings/0001345016-24-000060.md) | [72.2](/filings/0001345016-25-000030.md) | [70.4](/filings/0001345016-25-000041.md) | [69.2](/filings/0001345016-25-000071.md) | [67.3](/filings/0001345016-26-000040.md) | [65.7](/filings/0001345016-26-000066.md) | [64.2](/filings/0001345016-25-000071.md) | [59.4](/filings/0001345016-26-000040.md) | [55.7](/filings/0001345016-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,263,621 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001345016-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.